(MedPage Today) -- A relatively simple way to make progressive multifocal leukoencephalopathy more survivable appears to have worked in a multiple sclerosis patient taking natalizumab (Tysabri). via MedPageToday.com - medical news plus CME for physicians Read More Here..
Lake forest health and fitness http://ift.tt/1mZhdSV
No comments:
Post a Comment